|
1
|
Delsol G, Campo E and Gascoyne RD:
ALK-positive large B-cell lymphoma. WHO Classification of Tumours
of Haematopoietic and Lymphoid Tissues. Swerdlow S, Campo E, Harris
N, et al: Lyon: International Agency for Research on Cancer; pp.
254–255. 2008
|
|
2
|
Delsol G, Lamant L, Mariamé B, et al: A
new subtype of large B-cell lymphoma expressing the ALK kinase and
lacking the 2;5 translocation. Blood. 89:1483–1490. 1997.PubMed/NCBI
|
|
3
|
Morris SW, Kirstein MN, Valentine MB,
Dittmer K, Shapiro DN, Look AT and Saltman DL: Fusion of a kinase
gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s
lymphoma. Science. 267:316–317. 1995.
|
|
4
|
Gascoyne RD, Lamant L, Martin-Subero JI,
et al: ALK-positive diffuse large B-cell lymphoma is associated
with Clathrin-ALK rearrangements: report of 6 cases. Blood.
102:2568–2573. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De Paepe P, Baens M, van Krieken H, et al:
ALK activation by the CLTC-ALK fusion is a recurrent event in large
B-cell lymphoma. Blood. 102:2638–2641. 2003.PubMed/NCBI
|
|
6
|
Adam P, Katzenberger T, Seeberger H, et
al: A case of a diffuse large B-cell lymphoma of plasmablastic type
associated with the t(2;5)(p23;q35) chromosome translocation. Am J
Surg Pathol. 27:1473–1476. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Onciu M, Behm FG, Downing JR, et al:
ALK-positive plasmablastic B-cell lymphoma with expression of the
NPM-ALK fusion transcript: report of 2 cases. Blood. 102:2642–2644.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stachurski D, Miron PM, Al-Homsi S,
Hutchinson L, Harris NL, Woda B and Wang SA: Anaplastic lymphoma
kinase-positive diffuse large B-cell lymphoma with a complex
karyotype and cryptic 3’ ALK gene insertion to chromosome 4 q22-24.
Hum Pathol. 38:940–945. 2007.PubMed/NCBI
|
|
9
|
McManus DT, Catherwood MA, Carey PD,
Cuthbert RJ and Alexander HD: ALK-positive diffuse large B-cell
lymphoma of the stomach associated with a clathrin-ALK
rearrangement. Hum Pathol. 35:1285–1288. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reichard KK, McKenna RW and Kroft SH:
ALK-positive diffuse large B-cell lymphoma: report of four cases
and review of the literature. Mod Pathol. 20:310–319. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo B, Wang Y, Wang XF, Liang H, Yan LP,
Huang BH and Zhao P: Expression of Epstein-Barr virus genes in
EBV-associated gastric carcinomas. World J Gastroenterol.
11:629–633. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Beltran B, Castillo J, Salas R, et al:
ALK-positive diffuse large B-cell lymphoma: report of four cases
and review of the literature. J Hematol Oncol. 2:112009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee HW, Kim K, Kim W and Ko YH:
ALK-positive diffuse large B-cell lymphoma: report of three cases.
Hematol Oncol. 26:108–113. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Laurent C, Do C, Gascoyne RD, et al:
Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma:
a rare clinicopathologic entity with poor prognosis. J Clin Oncol.
27:4211–4216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tassone P, Goldmacher VS, Neri P, et al:
Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1
against CD138+ multiple myeloma cells. Blood. 104:3688–3696.
2004.PubMed/NCBI
|
